Save the date for our Xtalks Webinar on Thursday, February 22, 2024, from 11 a.m. – 12 p.m. ET: Brightplex®: An Enhanced Multiplex IHC Technology for Precision Oncology

Brightplex technology introduces a breakthrough extension to multiplex IHC by seamlessly integrating in situ hybridization (ISH) probes for the detection of RNA transcripts. In addition, Veracyte’s new spatial analysis tool offers the ability to analyze the distances between multiple cell populations of interest on sequential slides. This feature allows scientists and clinicians to explore spatial relationships within the tumor, providing critical information to better understand the tumor microenvironment.

Join us for this informative session where experts in the field, Jacques Fieschi, Ph.D., VP Research & Development at Veracyte, and Aurélie Auguste, Ph.D, Director Translational Data Analysis at Veracyte will describe the strengths of this technology.